105
Views
45
CrossRef citations to date
0
Altmetric
Original Research

A blockade of PD-L1 produced antitumor and antimetastatic effects in an orthotopic mouse pancreatic cancer model via the PI3K/Akt/mTOR signaling pathway

, , , , , , , & show all
Pages 2115-2126 | Published online: 12 Apr 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Chao-Qun Huang, Ping Yang, Jiuyang Liu, Yin-Ping Wang, Dan-Dan Hao & Xiaojun Yang. (2021) Circular RNA circ_0000423 promotes gastric cancer cell proliferation, migration and invasion via the microR-582-3p/Disheveled-Axin domain containing 1 axis. Bioengineered 12:2, pages 12755-12766.
Read now
Cong Bo, Qiang Wu, Hai Zhao, Xuebing Li & Qinghua Zhou. (2018) Thymosin α1 suppresses migration and invasion of PD-L1 high-expressing non-small-cell lung cancer cells via inhibition of STAT3–MMP2 signaling. OncoTargets and Therapy 11, pages 7255-7270.
Read now

Articles from other publishers (43)

Xiaoying Tan, Yan Li, Zhihui Hou, Mingwei Zhang, Li Li & Junmin Wei. (2023) Combination therapy with PD-1 inhibition plus rapamycin and metformin enhances anti-tumor efficacy in triple negative breast cancer. Experimental Cell Research, pages 113647.
Crossref
Duaa Alkaabi, Kholoud Arafat, Shahrazad Sulaiman, Aya Mudhafar Al-Azawi & Samir Attoub. (2023) PD-1 Independent Role of PD-L1 in Triple-Negative Breast Cancer Progression. International Journal of Molecular Sciences 24:7, pages 6420.
Crossref
Tomasz Wiśniowski, Jarosław Bryda & Sławomir Wątroba. (2023) The role of matrix metalloproteinases in pathogenesis, diagnostics, and treatment of human prostate cancer. Postępy Higieny i Medycyny Doświadczalnej 77:1, pages 9-20.
Crossref
Wenjuan Wang, Zhaohan Zhang, Minghui Zhao, Yu Wang, Yuze Ge & Lin Shan. (2023) Zinc-finger protein CXXC5 promotes breast carcinogenesis by regulating the TSC1/mTOR signaling pathway. Journal of Biological Chemistry 299:1, pages 102812.
Crossref
Wenjuan Wang, Xiaojiao Zhou, Yi Zhang, Zeyang Chen, Jinxia Huang, Xiaolu Zhang & Joanne Kwak-Kim. (2022) The characteristics of antigenic specificity of memory regulatory t cells in women with unexplained recurrent pregnancy loss. Journal of Reproductive Immunology 154, pages 103694.
Crossref
Ganji Purnachandra Nagaraju, Rama Rao Malla, Riyaz Basha & Ion G. Motofei. (2022) Contemporary clinical trials in pancreatic cancer immunotherapy targeting PD-1 and PD-L1. Seminars in Cancer Biology 86, pages 616-621.
Crossref
Kuan-Wei Su, Hung-Yun Lin, Hsien-Chung Chiu, Shin-Yu Shen, Chun A. ChangOu, Dana R. Crawford, Yu-Chen S. H. Yang, Ya-Jung Shih, Zi-Lin Li, Haw-Ming Huang, Jaqueline Whang-Peng, Yih Ho & Kuan Wang. (2022) Thyroid Hormone Induces Oral Cancer Growth via the PD-L1-Dependent Signaling Pathway. Cells 11:19, pages 3050.
Crossref
Xiaoming Sun, Yani Chen, Xiaoyang Tao, Wenzi Zhang, Xinyu Wang, Xianhui Wang, Zhihua Ruan & Zhuo Chen. (2022) INPP4B inhibits glioma cell proliferation and immune escape via inhibition of the PI3K/AKT signaling pathway. Frontiers in Oncology 12.
Crossref
Rong Qiu, Wenxi Wang, Juan Li & Yuxiang Wang. (2022) Roles of PTEN inactivation and PD-1/PD-L1 activation in esophageal squamous cell carcinoma. Molecular Biology Reports 49:7, pages 6633-6645.
Crossref
Ting Ding, Qian Song, Yanjun Xu & Qiya Liu. (2022) C-X-C Chemokine Receptor Type 4 (CXCR4) and Programmed Death-Ligand 1 (PD-L1) Expression are Prognostic Biomarkers for Papillary Thyroid Carcinoma. Journal of Biomaterials and Tissue Engineering 12:5, pages 953-957.
Crossref
Suman Kumar Ray & Sukhes Mukherjee. (2022) Directing Hypoxic Tumor Microenvironment and HIF to Illuminate Cancer Immunotherapy's Existing Prospects and Challenges in Drug Targets. Current Drug Targets 23:5, pages 471-485.
Crossref
Narges Dastmalchi, Shirin Azarbarzin, Reza Safaralizadeh, Seyed Mahdi Banan Khojasteh, Mahdi Abdoli Shadbad, Mohammad Amini, Amir Baghbanzadeh, Elmira Roshani Asl, Elham Baghbani, Parisa Lotfinejad & Behzad Baradaran. (2021) The combined therapy of miR-383-5p restoration and paclitaxel for treating MDA-MB-231 breast cancer. Medical Oncology 39:1.
Crossref
Ching-Chuan YehHsuan-Miao LiuMing-Chung LeeYann-Lii LeuWei-Han ChiangHen-Hong ChangTzung-Yan Lee. (2021) Phytochemical‑rich herbal formula ATG‑125 protects against sucrose‑induced gastrocnemius muscle atrophy by rescuing Akt signaling and improving mitochondrial dysfunction in young adult mice. Molecular Medicine Reports 25:2.
Crossref
Azza Naїja, Maysaloun Merhi, Varghese Inchakalody, Queenie Fernandes, Sarra Mestiri, Kirti S. Prabhu, Shahab Uddin & Said Dermime. (2021) The role of PAK4 in the immune system and its potential implication in cancer immunotherapy. Cellular Immunology 367, pages 104408.
Crossref
Seiya Inoue, Takahiro Yoshida, Takeshi Nishino, Masakazu Goto, Mariko Aoyama, Naoya Kawakita, Yota Yamamoto, Furukita Yoshihito, Hiromitsu Takizawa & Akira Tangoku. (2021) Biomarkers predicting the response to chemotherapy and the prognosis in patients with esophageal squamous cell carcinoma. General Thoracic and Cardiovascular Surgery 69:3, pages 525-533.
Crossref
Shirin Azarbarzin, Mohammad Ali Hosseinpour-Feizi, Seyed Mahdi Banan Khojasteh, Behzad Baradaran & Reza Safaralizadeh. (2021) MicroRNA -383-5p restrains the proliferation and migration of breast cancer cells and promotes apoptosis via inhibition of PD-L1. Life Sciences 267, pages 118939.
Crossref
Qijie Zhao, Jinan Guo, Yueshui Zhao, Jing Shen, Parham Jabbarzadeh Kaboli, Shixin Xiang, Fukuan Du, Xu Wu, Mingxing Li, Lin Wan, Xiang Li, Qinglian Wen, Jing Li, Chang Zou & Zhangang Xiao. (2020) Comprehensive assessment of PD-L1 and PD-L2 dysregulation in gastrointestinal cancers. Epigenomics.
Crossref
Mathias Fiedler, Daniela Schulz, Gerhard Piendl, Gero Brockhoff, Jonas Eichberger, Ayse-Nur Menevse, Philipp Beckhove, Matthias Hautmann, Torsten E. Reichert, Tobias Ettl & Richard J. Bauer. (2020) Buparlisib modulates PD-L1 expression in head and neck squamous cell carcinoma cell lines. Experimental Cell Research 396:1, pages 112259.
Crossref
Narges Dastmalchi, Mohammad Ali Hosseinpourfeizi, Seyed Mahdi Banan Khojasteh, Behzad Baradaran & Reza Safaralizadeh. (2020) Tumor suppressive activity of miR-424-5p in breast cancer cells through targeting PD-L1 and modulating PTEN/PI3K/AKT/mTOR signaling pathway. Life Sciences 259, pages 118239.
Crossref
Fabiana Conciatori, Chiara Bazzichetto, Italia Falcone, Ludovica Ciuffreda, Gianluigi Ferretti, Sabrina Vari, Virginia Ferraresi, Francesco Cognetti & Michele Milella. (2020) PTEN Function at the Interface between Cancer and Tumor Microenvironment: Implications for Response to Immunotherapy. International Journal of Molecular Sciences 21:15, pages 5337.
Crossref
Roopali Roy, Golnaz Morad, Andrej Jedinak & Marsha A. Moses. (2019) Metalloproteinases and their roles in human cancer. The Anatomical Record 303:6, pages 1557-1572.
Crossref
Yi‐Lin Chen, Gao‐Xiong Wang, Bei‐An Lin & Jing‐Shan Huang. (2020) MicroRNA‐93‐5p expression in tumor tissue and its tumor suppressor function via targeting programmed death ligand‐1 in colorectal cancer. Cell Biology International 44:5, pages 1224-1236.
Crossref
Alyssa Vito, Nader El-Sayes & Karen Mossman. (2020) Hypoxia-Driven Immune Escape in the Tumor Microenvironment. Cells 9:4, pages 992.
Crossref
Simona Romano, Martina Tufano, Paolo D’Arrigo, Vincenza Vigorito, Salvatore Russo & Maria Fiammetta Romano. (2020) Cell stemness, epithelial-to-mesenchymal transition, and immunoevasion: Intertwined aspects in cancer metastasis. Seminars in Cancer Biology 60, pages 181-190.
Crossref
Chiara Bazzichetto, Fabiana Conciatori, Claudio Luchini, Francesca Simionato, Raffaela Santoro, Vanja Vaccaro, Vincenzo Corbo, Italia Falcone, Gianluigi Ferretti, Francesco Cognetti, Davide Melisi, Aldo Scarpa, Ludovica Ciuffreda & Michele Milella. (2020) From Genetic Alterations to Tumor Microenvironment: The Ariadne’s String in Pancreatic Cancer. Cells 9:2, pages 309.
Crossref
Chiara Bazzichetto, Fabiana Conciatori, Italia Falcone & Ludovica Ciuffreda. 2020. Tumor Microenvironment. Tumor Microenvironment 69 80 .
Yu-Chen S.H. Yang, Zi-Lin Li, Ya-Jung Shih, James A. Bennett, Jaqueline Whang-Peng, Hung-Yun Lin, Paul J. Davis & Kuan Wang. (2019) Herbal Medicines Attenuate PD-L1 Expression to Induce Anti-Proliferation in Obesity-Related Cancers. Nutrients 11:12, pages 2979.
Crossref
Ruo Qiao Chen, Xiao Hong Xu, Feng Liu, Chun Yang Li, Yuan Jun Li, Xiang Rui Li, Guo Yong Jiang, Feng Hu, Di Liu, Feng Pan, Xin Yao Qiu & Xiao Qian Chen. (2019) The Binding of PD-L1 and Akt Facilitates Glioma Cell Invasion Upon Starvation via Akt/Autophagy/F-Actin Signaling. Frontiers in Oncology 9.
Crossref
Hong Liu, Ligang Zhang & Pengyan Wang. (2019) Complement factor H‑related 3 overexpression affects hepatocellular carcinoma proliferation and apoptosis. Molecular Medicine Reports.
Crossref
Jie Yu, Jie Shen, Xu Qiao, Longlei Cao, Zhangling Yang, Hui Ye, Changlei Xi, Qichang Zhou, Peiyun Wang & Zhilin Gong. (2019) SNHG20/miR‑140‑5p/NDRG3 axis contributes to 5‑fluorouracil resistance in gastric cancer. Oncology Letters.
Crossref
Guangfu Wang, Lingdi Yin, Yunpeng Peng, Yong Gao, Hao Gao, Jingjing Zhang, Nan Lv, Yi Miao & Zipeng Lu. (2019) Insulin promotes invasion and migration of KRAS G12D mutant HPNE cells by upregulating MMP‐2 gelatinolytic activity via ERK‐ and PI3K‐dependent signalling . Cell Proliferation 52:3, pages e12575.
Crossref
James RW Conway, David Herrmann, TR Jeffry Evans, Jennifer P Morton & Paul Timpson. (2019) Combating pancreatic cancer with PI3K pathway inhibitors in the era of personalised medicine. Gut 68:4, pages 742-758.
Crossref
Chiara Bazzichetto, Fabiana Conciatori, Matteo Pallocca, Italia Falcone, Maurizio Fanciulli, Francesco Cognetti, Michele Milella & Ludovica Ciuffreda. (2019) PTEN as a Prognostic/Predictive Biomarker in Cancer: An Unfulfilled Promise?. Cancers 11:4, pages 435.
Crossref
Hendrik Folkerts, Susan Hilgendorf, Edo Vellenga, Edwin Bremer & Valerie R. Wiersma. (2018) The multifaceted role of autophagy in cancer and the microenvironment. Medicinal Research Reviews 39:2, pages 517-560.
Crossref
Daniela Schulz, Irene Stancev, Antonio Sorrentino, Ayse-Nur Menevse, Philipp Beckhove, Gero Brockhoff, Matthias Günther Hautmann, Torsten Erich Reichert, Richard Josef Bauer & Tobias Ettl. (2019) Increased PD-L1 expression in radioresistant HNSCC cell lines after irradiation affects cell proliferation due to inactivation of GSK-3beta. Oncotarget 10:5, pages 573-583.
Crossref
Ruo Qiao Chen, Feng Liu, Xin Yao Qiu & Xiao Qian Chen. (2019) The Prognostic and Therapeutic Value of PD-L1 in Glioma. Frontiers in Pharmacology 9.
Crossref
Shan-Jen Lin, Yu-Tang Chin, Yih Ho, Szu-Yi Chou, Yu-Chen Sh Yang, André Wendindondé Nana, Kuan-Wei Su, Yee-Tong Lim, Kuan Wang, Sheng‐Yang Lee, Ya-Jung Shih, Yi-Ru Chen, Jacqueline Whang-Peng, Paul J. Davis, Hung-Yun Lin & Earl Fu. (2018) Nano-diamino-tetrac (NDAT) inhibits PD-L1 expression which is essential for proliferation in oral cancer cells. Food and Chemical Toxicology 120, pages 1-11.
Crossref
Martin Wartenberg, Silvia Cibin, Inti Zlobec, Erik Vassella, Serenella Eppenberger-Castori, Luigi Terracciano, Micha David Eichmann, Mathias Worni, Beat Gloor, Aurel Perren & Eva Karamitopoulou. (2018) Integrated Genomic and Immunophenotypic Classification of Pancreatic Cancer Reveals Three Distinct Subtypes with Prognostic/Predictive Significance. Clinical Cancer Research 24:18, pages 4444-4454.
Crossref
Caterina Fumagalli, Elena Guerini-Rocco, Davide Vacirca, Antonio Passaro, Filippo de Marinis & Massimo Barberis. (2018) The immune profile of EGFR -mutated non-small-cell lung cancer at disease onset and progression after tyrosine kinase inhibitors therapy . Immunotherapy 10:12, pages 1041-1045.
Crossref
Fabiana Conciatori, Chiara Bazzichetto, Italia Falcone, Sara Pilotto, Emilio Bria, Francesco Cognetti, Michele Milella & Ludovica Ciuffreda. (2018) Role of mTOR Signaling in Tumor Microenvironment: An Overview. International Journal of Molecular Sciences 19:8, pages 2453.
Crossref
Xin Yao Qiu, Dian Xing Hu, Wen-Qiang Chen, Ruo Qiao Chen, Shi Rui Qian, Chun Yang Li, Yuan Jun Li, Xin Xin Xiong, Di Liu, Feng Pan, Shang Bin Yu & Xiao Qian Chen. (2018) PD-L1 confers glioblastoma multiforme malignancy via Ras binding and Ras/Erk/EMT activation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1864:5, pages 1754-1769.
Crossref
Clayton S. Lewis, Christina Voelkel-Johnson & Charles D. Smith. 2018. Sphingolipids in Cancer. Sphingolipids in Cancer 295 325 .
Zhansheng Jiang, Yanfang Yang, Yinli Yang, Yu Zhang, Zhensong Yue, Zhanyu Pan & Xiubao Ren. (2017) Ginsenoside Rg3 attenuates cisplatin resistance in lung cancer by downregulating PD-L1 and resuming immune. Biomedicine & Pharmacotherapy 96, pages 378-383.
Crossref